Transverse Myelitis Trial, Recruiting NCT06280755 Sponsor: icometrix Condition: Transverse Myelitis
Back to Transverse Myelitis

Transverse Myelitis Trial, Recruiting

NCT06280755
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with one of the following conditions: Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD), MOG Antibody Disease (MOGAD), Clinically Isolated Syndrome (CIS), or Radiologically Isolated Syndrome (RIS) (confirm with trial site if unsure which applies to you).
  • You (or your legal representative) have previously agreed to allow your medical data to be used for research purposes, or this use of your data has been approved by an ethics review board in line with privacy laws.

Who may not be able to join:

  • You are under 18 years of age.
  • The trial doctors or steering committee have other reasons to believe that participation would not be appropriate for you, even if those reasons are not specifically listed (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Friedemann Paul, PhD, MD, Max Delbrück Center - Charite University, Berlin, Germany

Phone: +32 16 369 000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
icometrix
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
1 April 2027

Where this trial is recruiting

🇨🇿 Czechia 🇩🇪 Germany

Primary endpoints

The number of patients from each institution who have contributed data to the database.; The number of patients from each institution whose data was mapped to the common data model of the harmonised database.; The number of patients from the control arms of clinical trials who have contributed data to the database.; The data completeness of each variable in the harmonised database.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov